Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > ??

<< Previous

Bullboard Posts

Next >>

Comment by LaserStock29on Jun 01, 2022 10:14am

154 Views

Post# 34723040

RE:RE:RE:RE:RE:??

Is it possible to get the BTD along with AA together.. becuase if not then we're into mid 2023 minimum.

Every interaction with FDA reminds me of the old days with HC... 75 day cycles.. the horrors of those days will never be forgotten.

ScienceFirst wrote: For sure, the 12 under treated patients came complexified these stats.

But what I retain is that we were able to adjust and deliver excellent results, as a standalone treatment, enough to be a Breakthrough designation candidate and aim for revenues early 2023 if all goes well. That's what matters.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter